Overview
Michal Krauze, MD, PhD, is a medical oncologist at UPMC Hillman Cancer Center. He has a special interest in breast cancer, colon cancer, gastrointestinal oncology, thoracic oncology, lung cancer, genitourinary oncology, prostate cancer, and malignant hematology.
Dr. Krauze is rated as an Experienced provider by MediFind in the treatment of Melanoma. His top areas of expertise are Lung Adenocarcinoma, ALK-Positive Non-Small Cell Lung Cancer, Small Cell Lung Cancer (SCLC), and Squamous Cell Lung Carcinoma.
His clinical research consists of co-authoring 6 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Melanoma.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- MANAGED MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
200 Village Drive, Greensburg, PA 15601
800 Howard Avenue, Suite 1, Altoona, PA 16601
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
University Of Pittsburgh Physicians
Jason Luke is a Hematologist Oncology specialist and an Oncologist in Pittsburgh, Pennsylvania. Dr. Luke is rated as a Distinguished provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Metastatic Uveal Melanoma, Uveal Melanoma, Melanoma of the Eye, and Liver Embolization.
UPMC Hillman Cancer Center
John M. Kirkwood, MD, is a professor of medicine, dermatology, and clinical and translational science at the University of Pittsburgh School of Medicine and the Clinical and Translational Science Institute at the University of Pittsburgh. Dr. Kirkwood directs the Melanoma Center at UPMC Hillman Cancer Center and specializes in melanoma research and the prevention and early detection of melanoma, as well as the treatment of advanced disease and adjuvant therapy of resectable disease. Dr. Kirkwood is rated as a Distinguished provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Melanoma of the Eye, Metastatic Uveal Melanoma, and Uveal Melanoma.
UPMC Hillman Cancer Center
Yana G. Najjar, MD is a translational investigator and cutaneous oncologist at UPMC Hillman Cancer Center, where she also is an associate professor of medicine and Director of the Clinical and Translational Research Center. Dr. Najjar specializes in early phase clinical trials and in the treatment of advanced melanoma. Her research focusing on immunotherapy resistant melanoma and rare melanoma subtypes. She has developed multiple investigator-initiated trials that aim to remodel melanoma tumor cell metabolism and hypoxia in the tumor microenvironment to overcome mechanisms of resistance to immunotherapy. Her lab is focused on various correlative analyses from investigator-initiated trials. Dr. Najjar's research is funded by the NIH, the Department of Defense, and the Melanoma Research Alliance. Dr. Najjar is rated as a Distinguished provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Melanoma, Melanoma of the Eye, Metastatic Uveal Melanoma, Renal Cell Carcinoma (RCC), and Gamma Knife Radiosurgery.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Krauze isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Lung AdenocarcinomaDr. Krauze isDistinguished. Learn about Lung Adenocarcinoma.
- Pleuropulmonary BlastomaDr. Krauze isDistinguished. Learn about Pleuropulmonary Blastoma.
- Small Cell Lung Cancer (SCLC)Dr. Krauze isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Squamous Cell Lung CarcinomaDr. Krauze isDistinguished. Learn about Squamous Cell Lung Carcinoma.
- Advanced
- AnemiaDr. Krauze isAdvanced. Learn about Anemia.
- Chronic B-Cell Leukemia (CBCL)Dr. Krauze isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)
- EGFR Positive Lung CancerDr. Krauze isAdvanced. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Krauze isAdvanced. Learn about Large-Cell Lung Carcinoma.
- Lung CancerDr. Krauze isAdvanced. Learn about Lung Cancer.
- Experienced
- Acute Mountain SicknessDr. Krauze isExperienced. Learn about Acute Mountain Sickness.
- Adult Soft Tissue SarcomaDr. Krauze isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Krauze isExperienced. Learn about Agranulocytosis.
- Anal CancerDr. Krauze isExperienced. Learn about Anal Cancer.
- AngiosarcomaDr. Krauze isExperienced. Learn about Angiosarcoma.
- Antiphospholipid SyndromeDr. Krauze isExperienced. Learn about Antiphospholipid Syndrome.